YHO-13351 free base is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of cancer therapeutics. It acts as an inhibitor targeting specific proteins or pathways involved in tumor growth and proliferation. Its application is significant in preclinical studies to evaluate its efficacy and mechanism of action in various cancer models. Researchers also explore its potential in combination therapies to enhance treatment outcomes. Additionally, it is used in biochemical assays to understand cellular signaling pathways and to identify potential drug targets. Its role in advancing cancer research makes it a valuable compound in the pursuit of innovative therapeutic strategies.